Anixa Biosciences (ANIX) PT Raised to $9 at B.Riley/FBR, Following Positive EU Patent Decision
Tweet Send to a Friend
B.Riley/FBR analyst Andrew D\'Silva raised the price target on Anixa Biosciences (NASDAQ: ANIX) to $9.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
